Whit Mayo
Stock Analyst at Leerink Partners
(0.24)
# 3,869
Out of 4,670 analysts
199
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $7.56 | +5.82% | 2 | Nov 19, 2024 | |
| BK BNY Mellon | Maintains: Equal-Weight | $79 → $81 | $80.14 | +1.07% | 4 | Nov 15, 2024 | |
| RF Regions Financial | Maintains: Equal-Weight | $24 → $28 | $27.28 | +2.64% | 5 | Nov 15, 2024 | |
| PNC PNC Financial | Maintains: Overweight | $215 → $235 | $210.07 | +11.87% | 5 | Nov 15, 2024 | |
| FITB Fifth Third Bancorp | Maintains: Overweight | $52 → $54 | $47.90 | +12.73% | 4 | Nov 15, 2024 | |
| BAC Bank of America | Maintains: Overweight | $52 → $56 | $47.00 | +19.15% | 4 | Nov 15, 2024 | |
| MS Morgan Stanley | Upgrades: Equal-Weight | $107 → $142 | $134.69 | +5.43% | 5 | Nov 15, 2024 | |
| ARDT Ardent Health Partners | Maintains: Outperform | $23 → $25 | $15.83 | +57.93% | 2 | Nov 12, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $13 → $12 | $9.86 | +21.77% | 10 | Nov 6, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $298.11 | -16.14% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $101.12 | -1.11% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $5 | $7.00 | -28.57% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $18.75 | -20.00% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $71.09 | -26.85% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $69.84 | -21.25% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $590.87 | -5.22% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $197.94 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $60.58 | -37.27% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $602.78 | -35.30% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $97.50 | -0.51% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $221.12 | -29.90% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $19.60 | +2.04% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $328.45 | +1.99% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $402.55 | +44.08% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $90.64 | -6.22% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $324.93 | -11.98% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $23.01 | +73.84% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $21.56 | +80.89% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $3.37 | -55.49% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.89 | +1,487.30% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $14.96 | +6.95% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $143.63 | -61.71% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $38.23 | +169.42% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $76.57 | +128.55% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $12.05 | +57.68% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.65 | +9.59% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $239.67 | -15.30% | 2 | May 1, 2018 |
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $7.56
Upside: +5.82%
BNY Mellon
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $79 → $81
Current: $80.14
Upside: +1.07%
Regions Financial
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $24 → $28
Current: $27.28
Upside: +2.64%
PNC Financial
Nov 15, 2024
Maintains: Overweight
Price Target: $215 → $235
Current: $210.07
Upside: +11.87%
Fifth Third Bancorp
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $47.90
Upside: +12.73%
Bank of America
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $56
Current: $47.00
Upside: +19.15%
Morgan Stanley
Nov 15, 2024
Upgrades: Equal-Weight
Price Target: $107 → $142
Current: $134.69
Upside: +5.43%
Ardent Health Partners
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $15.83
Upside: +57.93%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.86
Upside: +21.77%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $298.11
Upside: -16.14%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $101.12
Upside: -1.11%
May 14, 2024
Downgrades: Market Perform
Price Target: $5
Current: $7.00
Upside: -28.57%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $18.75
Upside: -20.00%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $71.09
Upside: -26.85%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $69.84
Upside: -21.25%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $590.87
Upside: -5.22%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $197.94
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $60.58
Upside: -37.27%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $602.78
Upside: -35.30%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $97.50
Upside: -0.51%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $221.12
Upside: -29.90%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $19.60
Upside: +2.04%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $328.45
Upside: +1.99%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $402.55
Upside: +44.08%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $90.64
Upside: -6.22%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $324.93
Upside: -11.98%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $23.01
Upside: +73.84%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $21.56
Upside: +80.89%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $3.37
Upside: -55.49%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.89
Upside: +1,487.30%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $14.96
Upside: +6.95%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $143.63
Upside: -61.71%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $38.23
Upside: +169.42%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $76.57
Upside: +128.55%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $12.05
Upside: +57.68%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.65
Upside: +9.59%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $239.67
Upside: -15.30%